Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomarkers and computational models for predicting efficacy to tumor ICI immunotherapy
Yurong Qin, Miaozhe Huo, Xingwu Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13

Showing 13 citing articles:

Diagnostic value of a lactylation-related gene signature in hepatocellular carcinoma
Jiajia Zhang, Chunmei Dong, Lili Wu, et al.
Translational Cancer Research (2025) Vol. 14, Iss. 1, pp. 296-312
Open Access
Overview on biomarkers for immune oncology drugs
Evgeny N. Imyanitov, Elena V. Preobrazhenskaya, Natalia V. Mitiushkina
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Immune Modulation and Immunotherapy in Solid Tumors: Mechanisms of Resistance and Potential Therapeutic Strategies
Suman Giri, Gopal Lamichhane, Jitendra Pandey, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2923-2923
Open Access
Revisiting linear machine learning through the perspective of inverse problems
Shuang Liu, Sergey Kabanikhin, Sergei Strijhak, et al.
Journal of Inverse and Ill-Posed Problems (2025)
Closed Access
Advancements in Immunotherapy for Breast Cancer: Mechanisms, Efficacy, and Future Directions
Archita Rai, Swati G Deshpande, Ashish Vaidya, et al.
Cureus (2024)
Open Access | Times Cited: 2
The evolution of cancer immunotherapy: a comprehensive review of its history and current perspectives
Sana Ahuja, Sufian Zaheer
Korean Journal of Clinical Oncology (2024) Vol. 20, Iss. 2, pp. 51-73
Closed Access | Times Cited: 2
Nivolumab plus ipilimumab with chemotherapy in metastatic NSCLC: minireview and a case study of a patient negative for PD-L1
Alessandro Morabito
Drugs in Context (2024) Vol. 13, pp. 1-8
Open Access | Times Cited: 1
Comments on “Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses”
Kannan Raja
Oral Oncology (2024) Vol. 155, pp. 106897-106897
Closed Access
Continuing Discoveries in Immunogenetics and Computational Immunology: An Update
Giulia Russo, Elena Crispino, Esther M. Lafuente, et al.
Elsevier eBooks (2024)
Closed Access
Novel immunotherapy for multiple solid cancers using an Anti-HVEM blocking monoclonal antibody
Gilli Galore-Haskel, Efrat Merhavi-Shoham, Mika Shapiro, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Biomechanical regulation of anti-tumor immune responses in the TME
Kelly Kersten, Valerie M. Weaver
Elsevier eBooks (2024)
Closed Access
Commentary: Immune cell infiltration and prognostic index in cervical cancer: insights from metabolism-related differential genes
Fangshi Xu, Jiawei Lai
Frontiers in Immunology (2024) Vol. 15
Open Access
Immune Biomarkers and Predictive Signatures in Gastric Cancer: Optimizing Immunotherapy Responses
Sundaram Vickram, Shofia Saghya Infant, S. Manikandan, et al.
Pathology - Research and Practice (2024) Vol. 265, pp. 155743-155743
Closed Access
Page 1

Scroll to top